- Home
- CMRX vs CNOB Comparison
CMRX vs CNOB Comparison
Compare CMRX & CNOB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMRX
- CNOB
- Stock Information
- Founded
- CMRX 2000
- CNOB 1982
- Country
- CMRX United States
- CNOB United States
- Employees
- CMRX N/A
- CNOB N/A
- Industry
- CMRX Biotechnology: Pharmaceutical Preparations
- CNOB Major Banks
- Sector
- CMRX Health Care
- CNOB Finance
- Exchange
- CMRX Nasdaq
- CNOB Nasdaq
- Market Cap
- CMRX 797.3M
- CNOB 910.6M
- IPO Year
- CMRX 2013
- CNOB 1996
- Fundamental
- Price
- CMRX $8.54
- CNOB $21.56
- Analyst Decision
- CMRX Hold
- CNOB Buy
- Analyst Count
- CMRX 4
- CNOB 2
- Target Price
- CMRX $8.51
- CNOB $28.50
- AVG Volume (30 Days)
- CMRX 2.0M
- CNOB 231.2K
- Earning Date
- CMRX 04-30-2025
- CNOB 04-24-2025
- Dividend Yield
- CMRX N/A
- CNOB 3.34%
- EPS Growth
- CMRX N/A
- CNOB N/A
- EPS
- CMRX N/A
- CNOB 1.76
- Revenue
- CMRX $212,000.00
- CNOB $250,265,000.00
- Revenue This Year
- CMRX $2,416.04
- CNOB $45.94
- Revenue Next Year
- CMRX $923.92
- CNOB $29.36
- P/E Ratio
- CMRX N/A
- CNOB $12.25
- Revenue Growth
- CMRX N/A
- CNOB N/A
- 52 Week Low
- CMRX $0.75
- CNOB $17.07
- 52 Week High
- CMRX $8.55
- CNOB $29.31
- Technical
- Relative Strength Index (RSI)
- CMRX 80.86
- CNOB 40.28
- Support Level
- CMRX $8.50
- CNOB $21.09
- Resistance Level
- CMRX $8.55
- CNOB $21.94
- Average True Range (ATR)
- CMRX 0.02
- CNOB 1.20
- MACD
- CMRX -0.12
- CNOB -0.08
- Stochastic Oscillator
- CMRX 88.89
- CNOB 24.30
About CMRX Chimerix Inc.
Chimerix Inc. is a biopharmaceutical company based in the United States that engages in the research, development, and commercialization of medicines. Its portfolio includes treatment for acute myeloid leukemia (or AML) and antiviral treatment for smallpox. The company generates revenue through revenue related to non-refundable upfront fees, royalties and milestone payments earned under license agreements, also by royalty revenue related to sales of TEMBEXA made by Emergent after the Asset Sale. The company operates only in one business segment namely pharmaceuticals.
About CNOB ConnectOne Bancorp Inc.
ConnectOne Bancorp Inc is a community-based, full-service New Jersey-chartered commercial bank. Substantially all loans are secured with various types of collateral, including business assets, consumer assets and commercial/residential real estate. Each borrower's ability to repay its loans is dependent on the conversion of assets, cash flows generated from the borrowers' business, real estate rental and consumer wages.